News
Repros Therapeutics stock more than doubles on positive study results for Androxal Yahoo/AP
View ArticleRepros Therapeutics gets FDA go-ahead on testosterone drug study
Repros Therapeutics gets FDA go-ahead on testosterone drug study Reuters
View ArticleRepros testosterone drug hits main goals of key study
Repros testosterone drug hits main goals of key study Reuters
View ArticleRepros Therapeutics files IP rights action in Texas
Repros Therapeutics files IP rights action in Texas The Fly on the Wall
View ArticleRepros Therapeutics: Winning The Battle But Losing The War?
Repros Therapeutics: Winning The Battle But Losing The War? Seeking Alpha
View ArticleRepros reported additional topline results from study for Androxal
Repros reported additional topline results from study for Androxal Yahoo/Fly on the Wall
View ArticleRepros plummets as FDA questions testosterone drug data
Repros plummets as FDA questions testosterone drug data Fierce Biotech
View ArticleFDA Schedules Face to Face Meeting With Repros to Discuss Androxal(R) Efficacy
FDA Schedules Face to Face Meeting With Repros to Discuss Androxal(R) Efficacy Yahoo
View ArticleRepros Meets With FDA to Discuss Data Requirements for Androxal(R) in the...
Repros Meets With FDA to Discuss Data Requirements for Androxal(R) in the Treatment of Secondary Hypogonadism Yahoo
View ArticleRepros Shares Soar After FDA Meeting
Repros Shares Soar After FDA Meeting Yahoo/Zacks.com
View Article
